Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
🇪🇸 Spain Applicant Guide 2025
Quick Facts for Spain Applicants
Ready to Apply from Spain?
Get a personalized assessment tailored for Spain applicants
See in 5 min if your Spain organization qualifies for €80.0M funding💰 Funding Details
Funding Description
What the Grant Funds
* Coordination & Support Action (CSA) that sustains and evolves the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R).
* Lump-sum grant of up to €80 million to cover the full work plan (single beneficiary or consortium).
* Eligible cost items (covered by the lump sum):
* Secretariat staffing (administrative, scientific & communications personnel).
* Operation of regional hubs, working groups and scientific advisory panels.
* Digital infrastructure: knowledge-management platforms, data dashboards, secure communication tools, website, social-media channels.
* Meetings & events: Board meetings, yearly General Assembly, rapid-response workshops, stakeholder fora.
* External communications: newsletters, policy briefs, multimedia, translations.
* Rapid-reaction envelopes to scale up support during outbreaks (e.g. surge staff, emergency convenings, situational analyses).
Eligibility Snapshot
* Coordinator: Legal entity established in an EU Member State or Horizon Europe Associated Country.
* Consortium (recommended):
* Minimum 3 independent legal entities from 3 different EU/Associated Countries (standard HE rule), but a large, globally representative consortium is strongly advised to mirror GloPID-R’s reach.
* US participants (e.g. NIH) may receive EU funding (exceptionally allowed).
* International organisations (e.g. WHO) may join as associated partners.
* Countries not automatically eligible can participate with own funding; many (e.g. Canada, Japan) have national provisions.
Key Grant Facts
* Call ID: HORIZON-HLTH-2025-01-DISEASE-05
* Action type: HORIZON-CSA (Lump Sum)
* Destination: Tackling diseases & reducing disease burden
* Opening date: 22 May 2025
* Deadline (single stage): 16 Sep 2025 – 17:00 Brussels time
* Project length: Indicative 48–60 months (justify in work plan)
* Funding rate: 100 % of the agreed lump sum
What Success Looks Like
* A dynamic, agile secretariat that demonstrably increases the speed, coordination quality and global visibility of research-funding responses during epidemics.
* Delivery of annual work plans, evidence syntheses, data-sharing frameworks, clinical-trial coordination tools and sustained stakeholder engagement.
* Clear alignment with EU health-security priorities (HERA, European Health Union) and WHO R&D Blueprint.
🇪🇸Spain Overview
🏷️ Keywords
Related Opportunities for Spain
Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections
Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential
Leveraging artificial intelligence for pandemic preparedness and response
Ready to Apply from Spain?
Get a personalized assessment tailored for Spain applicants
See if your Spain organization qualifies for €80.0M fundingFrequently Asked Questions
Common questions about Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) for Spain applicants